Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

Risultato della ricerca: Review article

Lingua originaleEnglish
pagine (da-a)152-153-153
Numero di pagine2
RivistaThrombosis Research
Volume158
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • Hematology

Cita questo

@article{848cbba99d4447b595f4cde70e00dd26,
title = "Prolonged anticoagulant treatment in patients with cancer: Where do we stand?",
keywords = "Bleeding; Cancer associated thrombosis; Low molecular weight heparin; Recurrences; Tinzaparin",
author = "Sergio Siragusa and Mariasanta Napolitano",
year = "2017",
language = "English",
volume = "158",
pages = "152--153--153",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

AU - Siragusa, Sergio

AU - Napolitano, Mariasanta

PY - 2017

Y1 - 2017

KW - Bleeding; Cancer associated thrombosis; Low molecular weight heparin; Recurrences; Tinzaparin

UR - http://hdl.handle.net/10447/248787

UR - http://www.elsevier.com/locate/thromres

M3 - Review article

VL - 158

SP - 152-153-153

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -